Mark Terence P Mujer, Manoj P Rai, Varunsiri Atti, Ian Limuel Dimaandal, Abigail S Chan, Shiva Shrotriya, Krishna Gundabolu, Prajwal Dhakal
Non-vitamin K antagonist oral anticoagulants (NOACs) include thrombin inhibitor dabigatran and coagulation factor Xa inhibitors rivaroxaban, apixaban, edoxaban, and betrixaban. NOACs have several benefits over warfarin, including faster time to the achieve effect, rapid onset of action, fewer documented food and drug interactions, lack of need for routine INR monitoring, and improved patient satisfaction. Local hemostatic measures, supportive care, and withholding the next NOAC dose are usually sufficient to achieve hemostasis among patients presenting with minor bleeding...
2020: Advances in Hematology